We have previously demonstrated that LPS treatment, a common model of gram-negative bacterial infection, impairs ABCG2 and BCRP expression in first trimester human placental explants, but had no effect when administered to third trimester placental explants [11]. Here, ABCG2 is linked to gram-negative bacterial infections.